CALA - Calithera Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
51,058
48,475
10,601
6,105
Short Term Investments
85,095
115,318
41,180
63,823
Total Cash
136,153
186,154
51,781
71,925
Net Receivables
1,997
1,142
-
-
Inventory
-
-
-
-
Other Current Assets
-
0
0
0
Total Current Assets
140,252
167,667
53,561
72,495
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,208
3,999
2,780
2,529
Accumulated Depreciation
-2,744
-2,240
-1,881
-1,598
Net property, plant and equipment
1,464
1,759
899
931
Equity and other investments
0
22,361
0
1,997
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
1,009
668
336
327
Total non-current assets
2,473
24,788
1,235
3,255
Total Assets
142,725
192,455
54,796
75,750
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
1,247
1,072
398
562
Taxes payable
-
-
-
-
Accrued liabilities
11,167
8,938
4,055
3,271
Deferred revenues
2,467
29,017
-
-
Other Current Liabilities
-
0
0
0
Total Current Liabilities
14,881
39,027
4,453
3,833
Non-current liabilities
Long Term Debt
-
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
0
31,045
-
-
Other long-term liabilities
-
0
0
0
Total non-current liabilities
1,130
3,121
437
129
Total Liabilities
16,011
42,148
4,890
3,962
Stockholders' Equity
Common Stock
4
4
2
2
Retained Earnings
-196,170
-150,333
-122,502
-84,498
Accumulated other comprehensive income
-113
-270
-13
-69
Total stockholders' equity
-196,170
-150,333
-122,502
-84,498
Total liabilities and stockholders' equity
142,725
192,455
54,796
75,750